01763.HK
China Isotope & Radiation Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 11.74
−4.40%Year over year
Reported trailing growth
- Revenue
- -6.4%
- EBITDA
- -9.5%
- EBIT
- -18.7%
- EPS
- -27.8%
- Free cash flow
- +131.6%
- Operating cash flow
- +5777.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- +2.5%
- EBIT
- +0.1%
- Net income
- -6.7%
- EPS
- -6.7%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026